Home / Europe / Switzerland

Switzerland

Europe

CMS von Erlach Partners is a leading full-service law firm in Switzerland with more than 110 lawyers and tax experts and a total staff exceeding 160 employees.

Our history dates back to more than 80 years, and our reputation in the market for legal and tax services has been strong and established ever since. We serve our clients from our offices in Switzerland's main business centres, Zurich and Geneva.

Our experts advise Swiss and international companies, including multinationals, financial institutions, start-ups, government agencies, public utilities, entrepreneurs and individuals across all industries and fields of law.  

Local expertise. Global perspective.

As your business partner, we offer you our local expertise combined with the global reach and capabilities of CMS international, with access to 5,000+ lawyers worldwide in 75+ offices in more than 40 countries.

Serving you well.

We believe that legal advice should represent good value for money. Known for our industry-shaping solutions and our distinctive and innovative personal approach, we focus on strong, agile relationships that are beneficial to our clients. When working with you we consider ourselves not to be just your legal advisers, but your business partners. We understand your unique needs and strive to anticipate potential challenges you may face now and in the future. We provide innovative, tailor-made solutions that underscore our dedication to quality, excellence and your satisfaction.

Our legal and tax experts across every sector.

Our legal and tax experts are genuine experts in their fields. That depth of knowledge gives us the ability to anticipate challenges – and our collective experience allows us to meet them in innovative ways. Many of our experts are listed in the leading legal directories and recognised by clients and peers as thought leaders in their fields.  

Read more Read less
About us
Awards & Rankings
Corporate Video
The Future of Law

Feed

25/04/2024
CMS Expert Guide to advertising of medicines and medical devices
Advertising of pharmaceuticals and medical devices is a challenging area for the Life Sciences and Healthcare industry. The legal framework is constantly changing. Due to very few laws on this area, there...
24/04/2024
CMS Expert Guide to Anti-Bribery and Corruption Laws
We are delighted to present the 7th edition of the CMS Guide to Anti-Bribery and Corruption Laws. Guide is now available in both offline PDF format and online on our website. The purpose of the Guide...
23/04/2024
On the Pulse webinar series 2024
Welcome to the 2024 On the Pulse webinar series.  This webinar series brings you updates on the latest legal and commercial developments in the life sciences & healthcare sector from around the world. Over the coming period, we will be hosting two webinars on:Unified Patent Court (UPC) - 23 AprilEU Pharma Package - 18 JuneEach webinar will be one hour in length with a 15-minute Q&A session.
18/04/2024
Transforming the Legal Landscape? The Impact of LLMs
Large Language Models (LLMs) are a branch of artificial intelligence (AI) that can generate human-like text based on deep learning techniques. LLMs are trained on massive amounts of textual data, such...
18/04/2024
CMS Expert Guide to real estate finance law
A clear understanding of the security available is fundamental for lenders and borrowers. To assist, CMS has launched an interactive International Guide to Real Estate Finance. This provides a clear and...
18/04/2024
CMS Expert Guide to renewable energy
The Renewables Sector is now many decades old and considered a mature investment sector by many. Yet the issues it faces continue to evolve and grow at pace with the evolution and growth of the sector...
17/04/2024
CMS data protection update (04/2024)
I. The latest from the data protection authorities and current topics1. EDPB: Launch of coordinated enforcement on the right of accessThe European Data Protection Board (EDPB) selected the right of access...
11/04/2024
Navigating clinical trial disclosures: No reasonable expectation of success...
Recent EPO Board of Appeal decision T 1437/21 adds to a growing number of decisions concerning the patentability of second or further medical use inventions where the prior art relates to a clinical trial...
09/04/2024
CMS European M&A Study 2024: Optimism for M&A amid evolving market trends
The CMS Corporate/M&A Group is pleased to launch the 16th edition of the European M&A Study.It's been a wild ride for mergers and acquisitions (M&A) around the world this year. Yet, despite the turbulence...
09/04/2024
Designs practice update: EU Court of Justice upholds Advocate General’s...
BackgroundIn our previous article (here), we discussed the opinion of Advocate General Capeta in EUIPO v The KaiKai Company Jaeger Wichmann. That opinion was provided following an appeal against the General...
09/04/2024
Federal Council issues preliminary draft of new Administrative Criminal...
On 31 January 2024, the Swiss Federal Council suggested a total revision of the Administrative Criminal Law Act of 22 March 1974 (ACLA) and issued a preliminary draft including an explanatory re­port.Ac­cord­ing...
09/04/2024
The sum of parts: Registered design for segments of towers found valid...
BackgroundTA Towers ApS (“TA Towers”), a company based in Denmark, is the holder of the below registered Community design relating to goods for building materials, specifically, ‘building materials...